Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Eastern Cooperative Oncology Group

Home Clinical Trial Sponsors and OrganizationsEastern Cooperative Oncology Group

Eastern Cooperative Oncology Group

ACTIVE

1818 Market St Lbby 100, 宾夕法尼亚州费拉德尔菲亚县, Pennsylvania, United Statesecog-acrin.orgPrivate51–100 employeesEstablished: 2012-01-01

Part of ECOG-ACRIN Medical Research Foundation, Inc.

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

179

8 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

2012

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 2

98

54.8%

Phase 3

41

22.9%

Not Applicable

10

5.6%

Phase 1

5

2.8%

Trial Status Distribution

Active, not recruiting

4

2.2%

Completed

147

82.1%

Not yet recruiting

4

2.2%

Recruiting

5

2.8%

Terminated

10

5.6%

Unknown

1

0.6%

Withdrawn

8

4.5%

Clinical Trials

Trials sponsored by this organization (179)

Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney Failure

Mar 202674 participants

Sulforaphane for the Prevention of Melanoma in Patients With Multiple Atypical Nevi and a Prior History of Melanoma

Feb 2026120 participants

A Randomized Phase III Study of Management of Treatment Naive Primary Melanoma in Elderly Patients

Not yet recruiting

Dec 2025428 participants

A Targeted Electronic Health Approach to Reduce Fear of Recurrence in Breast Cancer Survivors (FoRtitude)

Not yet recruiting

Sep 2025800 participants

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Jun 2025294 participants

Extended Clinical Follow up and Biospecimen Collection for Patients Enrolled in TAILORx and RxPONDER: A Companion Protocol

Not yet recruiting

Jun 2025600 participants

The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials

Apr 2025500 participants

Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia (AML) Following Initial Treatment

Not yet recruiting

Oct 2024184 participants

Page 1 of 23

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials179
Approvals
News

Back to Organizations